vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and IT TECH PACKAGING, INC. (ITP). Click either name above to swap in a different company.
IT TECH PACKAGING, INC. is the larger business by last-quarter revenue ($25.6M vs $24.8M, roughly 1.0× Ceribell, Inc.). IT TECH PACKAGING, INC. runs the higher net margin — -5.7% vs -54.6%, a 48.9% gap on every dollar of revenue. IT TECH PACKAGING, INC. produced more free cash flow last quarter ($1.5M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.
CBLL vs ITP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $24.8M | $25.6M |
| Net Profit | $-13.5M | $-1.4M |
| Gross Margin | 87.3% | 7.9% |
| Operating Margin | -58.9% | -3.9% |
| Net Margin | -54.6% | -5.7% |
| Revenue YoY | — | 2.1% |
| Net Profit YoY | — | 26.6% |
| EPS (diluted) | $-0.35 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | — | ||
| Q3 25 | $22.6M | $25.6M | ||
| Q2 25 | $21.2M | $24.8M | ||
| Q1 25 | $20.5M | $10.9M | ||
| Q4 24 | — | $17.6M | ||
| Q3 24 | $17.2M | $25.1M | ||
| Q2 24 | — | $26.2M | ||
| Q1 24 | — | $6.9M |
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $-1.4M | ||
| Q2 25 | $-13.6M | $-2.0M | ||
| Q1 25 | $-12.8M | $-3.5M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | $-10.4M | $-2.0M | ||
| Q2 24 | — | $-77.7K | ||
| Q1 24 | — | $-3.7M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | 7.9% | ||
| Q2 25 | 88.1% | 5.1% | ||
| Q1 25 | 87.9% | 0.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | 87.3% | 7.6% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | 5.8% |
| Q4 25 | -58.9% | — | ||
| Q3 25 | -64.8% | -3.9% | ||
| Q2 25 | -70.5% | -7.1% | ||
| Q1 25 | -69.3% | -31.0% | ||
| Q4 24 | — | -21.5% | ||
| Q3 24 | -57.8% | -5.8% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | -51.0% |
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | -5.7% | ||
| Q2 25 | -64.4% | -7.9% | ||
| Q1 25 | -62.4% | -32.2% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | -60.6% | -7.9% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | -54.6% |
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.37 | $-0.11 | ||
| Q2 25 | $-0.38 | $-0.16 | ||
| Q1 25 | $-0.36 | $-0.35 | ||
| Q4 24 | — | $-0.40 | ||
| Q3 24 | $-1.85 | $-0.20 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | — |
| Total DebtLower is stronger | — | $4.7M |
| Stockholders' EquityBook value | $155.3M | $152.0M |
| Total Assets | $195.8M | $175.7M |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $4.7M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $4.7M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | — | $8.9M | ||
| Q2 24 | — | $11.3M | ||
| Q1 24 | — | $11.4M |
| Q4 25 | $155.3M | — | ||
| Q3 25 | $164.1M | $152.0M | ||
| Q2 25 | $172.2M | $152.3M | ||
| Q1 25 | $180.9M | $152.8M | ||
| Q4 24 | — | $156.1M | ||
| Q3 24 | $-136.0M | $164.3M | ||
| Q2 24 | — | $163.5M | ||
| Q1 24 | — | $164.3M |
| Q4 25 | $195.8M | — | ||
| Q3 25 | $199.5M | $175.7M | ||
| Q2 25 | $207.7M | $175.2M | ||
| Q1 25 | $213.5M | $175.2M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | $47.1M | $190.0M | ||
| Q2 24 | — | $191.4M | ||
| Q1 24 | — | $177.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $1.5M |
| Free Cash FlowOCF − Capex | $-11.0M | $1.5M |
| FCF MarginFCF / Revenue | -44.2% | 5.9% |
| Capex IntensityCapex / Revenue | 0.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $3.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | — | ||
| Q3 25 | $-11.1M | $1.5M | ||
| Q2 25 | $-7.5M | $1.4M | ||
| Q1 25 | $-11.4M | $-2.5M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $721.9K | ||
| Q1 24 | — | $624.4K |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | $1.5M | ||
| Q2 25 | $-7.6M | $1.3M | ||
| Q1 25 | $-11.6M | $-2.5M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $668.3K | ||
| Q1 24 | — | $615.4K |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | 5.9% | ||
| Q2 25 | -35.9% | 5.4% | ||
| Q1 25 | -56.4% | -22.8% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 9.0% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
ITP
Segment breakdown not available.